Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Mol Cell ; 47(5): 755-66, 2012 Sep 14.
Artigo em Inglês | MEDLINE | ID: mdl-22819324

RESUMO

The T7 phage-encoded small protein Gp2 is a non-DNA-binding transcription factor that interacts with the jaw domain of the Escherichia coli (Ec) RNA polymerase (RNAp) ß' subunit and inhibits transcriptionally proficient promoter-complex (RPo) formation. Here, we describe the high-resolution solution structure of the Gp2-Ec ß' jaw domain complex and show that Gp2 and DNA compete for binding to the ß' jaw domain. We reveal that efficient inhibition of RPo formation by Gp2 requires the amino-terminal σ(70) domain region 1.1 (R1.1), and that Gp2 antagonizes the obligatory movement of R1.1 during RPo formation. We demonstrate that Gp2 inhibits RPo formation not just by steric occlusion of the RNAp-DNA interaction but also through long-range antagonistic effects on RNAp-promoter interactions around the RNAp active center that likely occur due to repositioning of R1.1 by Gp2. The inhibition of Ec RNAp by Gp2 thus defines a previously uncharacterized mechanism by which bacterial transcription is regulated by a viral factor.


Assuntos
RNA Polimerases Dirigidas por DNA/antagonistas & inibidores , Escherichia coli/enzimologia , Proteínas Repressoras/metabolismo , DNA Bacteriano/química , DNA Bacteriano/efeitos dos fármacos , RNA Polimerases Dirigidas por DNA/química , RNA Polimerases Dirigidas por DNA/metabolismo , Modelos Moleculares , Regiões Promotoras Genéticas/efeitos dos fármacos , Regiões Promotoras Genéticas/genética , Conformação Proteica , Proteínas Repressoras/química , Proteínas Repressoras/genética , Transcrição Gênica/efeitos dos fármacos , Transcrição Gênica/genética , Ativação Transcricional/efeitos dos fármacos , Ativação Transcricional/genética
2.
Microbiology (Reading) ; 158(Pt 11): 2753-2764, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22977089

RESUMO

The Escherichia coli-infecting bacteriophage T7 encodes a 7 kDa protein, called Gp2, which is a potent inhibitor of the host RNA polymerase (RNAp). Gp2 is essential for T7 phage development. The interaction site for Gp2 on the E. coli RNAp is the ß' jaw domain, which is part of the DNA binding channel. The binding of Gp2 to the ß' jaw antagonizes several steps associated with interactions between the RNAp and promoter DNA, leading to inhibition of transcription at the open promoter complex formation step. In the structure of the complex formed between Gp2 and a fragment of the ß' jaw, amino acid residues in the ß3 strand of Gp2 contribute to the primary interaction interface with the ß' jaw. The 7009 E. coli strain is resistant to T7 because it carries a charge reversal point mutation in the ß' jaw that prevents Gp2 binding. However, a T7 phage encoding a mutant form of Gp2, called Gp2(ß), which carries triple amino acid substitutions E24K, F27Y and R56C, can productively infect this strain. By studying the molecular basis of inhibition of RNAp from the 7009 strain by Gp2(ß), we provide several lines of evidence that the E24K and F27Y substitutions facilitate an interaction with RNAp when the primary interaction interface with the ß' jaw is compromised. The proposed additional interaction interface between RNAp and Gp2 may contribute to the multipronged mechanism of transcription inhibition by Gp2.


Assuntos
Bacteriófago T7/metabolismo , RNA Polimerases Dirigidas por DNA/metabolismo , Inibidores Enzimáticos/metabolismo , Proteínas de Escherichia coli/metabolismo , Escherichia coli/enzimologia , Proteínas Repressoras/genética , Proteínas Repressoras/metabolismo , Transcrição Gênica , Sequência de Aminoácidos , Substituição de Aminoácidos , Bacteriófago T7/química , Bacteriófago T7/genética , Sítios de Ligação , RNA Polimerases Dirigidas por DNA/antagonistas & inibidores , RNA Polimerases Dirigidas por DNA/química , RNA Polimerases Dirigidas por DNA/genética , Regulação para Baixo , Inibidores Enzimáticos/química , Escherichia coli/química , Escherichia coli/genética , Proteínas de Escherichia coli/antagonistas & inibidores , Proteínas de Escherichia coli/química , Proteínas de Escherichia coli/genética , Dados de Sequência Molecular , Proteínas Repressoras/química , Alinhamento de Sequência , Proteínas Virais
3.
J Control Release ; 321: 654-668, 2020 05 10.
Artigo em Inglês | MEDLINE | ID: mdl-32114092

RESUMO

Persistent high-risk HPV infection is the main factor for cervical cancer. HPV E7 oncogene plays an important role in HPV carcinogenesis. Down-regulation of E7 oncogene expression could induce growth inhibition in HPV-positive cells and thus treats HPV related cervical cancer. Here we developed a non-virus gene vector based on poly(amide-amine)-poly(ß-amino ester) hyperbranched copolymer (hPPC) for the delivery of CRISPR/Cas9 system to specifically cleave HPV E7 oncogene in HPV-positive cervical cancer cells. The diameter of polyplex nanoparticles (NPs) formed by hPPCs/linear poly(ß-amino ester) (PBAE) and plasmids were approximately 300 nm. These hPPCs/PBAE-green fluorescence protein plasmids polyplex NPs showed high transfection efficiency and low toxicity in cells and mouse organs. By cleaving HPV16 E7 oncogene, reducing the expression of HPV16 E7 protein and increasing intracellular retinoblastoma 1 (RB1) amount, hPPCs/PBAE-CRISPR/Cas9 therapeutic plasmids polyplex NPs, especially highly branched hPPC1-plasmids polyplex NPs, exhibited strong growth inhibition of cervical cancer cells in vitro and xenograft tumors in nude mice. Together, the hPPCs/PBAE polyplex NPs to deliver HPV16 E7 targeted CRISPR/Cas9 system in this study could potentially be applied to treat HPV-related cervical cancer.


Assuntos
Infecções por Papillomavirus , Polímeros , Neoplasias do Colo do Útero , Animais , Sistemas CRISPR-Cas , Sistemas de Liberação de Medicamentos , Ésteres , Feminino , Humanos , Camundongos , Camundongos Nus , Proteínas E7 de Papillomavirus/genética , Infecções por Papillomavirus/terapia , Neoplasias do Colo do Útero/genética , Neoplasias do Colo do Útero/terapia
4.
EBioMedicine ; 58: 102897, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-32711250

RESUMO

BACKGROUND: Gene therapy has held promises for treating specific genetic diseases. However, the key to clinical application depends on effective gene delivery. METHODS: Using a large animal model, we developed two pharmaceutical formulations for gene delivery in the pigs' vagina, which were made up of poly (ß-amino ester) (PBAE)-plasmid polyplex nanoparticles (NPs) based two gel materials, modified montmorillonite (mMMT) and hectorite (HTT). FINDINGS: By conducting flow cytometry of the cervical cells, we found that PBAE-GFP-NPs-mMMT gel was more efficient than PBAE-GFP-NPs-HTT gel in delivering exogenous DNA intravaginally. Next, we designed specific CRISPR/SpCas9 sgRNAs targeting porcine endogenous retroviruses (PERVs) and evaluated the genome editing efficacy in vivo. We discovered that PERV copy number in vaginal epithelium could be significantly reduced by the local delivery of the PBAE-SpCas9/sgRNA NPs-mMMT gel. Comparable genome editing results were also obtained by high-fidelity version of SpCas9, SpCas9-HF1 and eSpCas9, in the mMMT gel. Further, we confirmed that the expression of topically delivered SpCas9 was limited to the vagina/cervix and did not diffuse to nearby organs, which was relatively safe with low toxicity. INTERPRETATION: Our data suggested that the PBAE-NPs mMMT vaginal gel is an effective preparation for local gene therapy, yielding insights into novel therapeutic approaches to sexually transmitted disease in the genital tract. FUNDING: This work was supported by the National Science and Technology Major Project of the Ministry of science and technology of China (No. 2018ZX10301402); the National Natural Science Foundation of China (81761148025, 81871473 and 81402158); Guangzhou Science and Technology Programme (No. 201704020093); National Ten Thousand Plan-Young Top Talents of China, Fundamental Research Funds for the Central Universities (17ykzd15 and 19ykyjs07); Three Big Constructions-Supercomputing Application Cultivation Projects sponsored by National Supercomputer Center In Guangzhou; the National Research FFoundation (NRF) South Africa under BRICS Multilateral Joint Call for Proposals; grant 17-54-80078 from the Russian Foundation for Basic Research.


Assuntos
Colo do Útero/citologia , Retrovirus Endógenos/genética , Dosagem de Genes/efeitos dos fármacos , Polímeros/química , RNA Guia de Cinetoplastídeos/administração & dosagem , Administração Intravaginal , Animais , Bentonita/química , Sistemas CRISPR-Cas , Células Cultivadas , Colo do Útero/química , Retrovirus Endógenos/efeitos dos fármacos , Feminino , Edição de Genes , Terapia Genética , Camundongos , Modelos Animais , Nanopartículas , Plasmídeos/administração & dosagem , Plasmídeos/genética , Silicatos/química , Suínos , Cremes, Espumas e Géis Vaginais
5.
J Mol Biol ; 359(5): 1182-95, 2006 Jun 23.
Artigo em Inglês | MEDLINE | ID: mdl-16725156

RESUMO

The bacterial RNA polymerase (RNAP) is a multi-subunit, structurally flexible, complex molecular machine, in which activities associated with DNA opening for transcription-competent open promoter complex (OC) formation reside in the catalytic beta and beta' subunits and the dissociable sigma subunit. OC formation is a multi-step process that involves several structurally conserved mobile modules of beta, beta', and sigma. Here, we present evidence that two flexible modules of beta', the beta' jaw and the beta' clamp and a conserved regulatory Region I domain of sigma(54), jointly contribute to the maintenance of stable DNA strand separation around the trancription start site in OCs formed at sigma(54)-dependent promoters. Clearly, regulated interplay between the mobile modules of the beta' and the sigma subunits of the RNAP appears to be necessary for stable OC formation.


Assuntos
RNA Polimerases Dirigidas por DNA/química , RNA Polimerases Dirigidas por DNA/metabolismo , DNA/química , DNA/metabolismo , Escherichia coli/enzimologia , Regiões Promotoras Genéticas/genética , RNA Polimerase Sigma 54/metabolismo , Heparina/farmacologia , Modelos Moleculares , Mutação/genética , Conformação de Ácido Nucleico , Estrutura Terciária de Proteína , Proteínas Repressoras/metabolismo , Sítio de Iniciação de Transcrição , Transcrição Gênica
6.
Methods Mol Biol ; 905: 73-86, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22735999

RESUMO

The Northern blot technique is widely used to study RNA. This relatively old method allows one to detect RNA molecules ranging in size from ∼20 to thousands of nucleotides and simultaneously estimate the size of an RNA and detect its degradation/processing products. The method does not rely on enzymes such as reverse transcriptases or RNA ligases used in most advanced RNA detection methods, which can be advantageous since biases in detection of individual RNAs can be avoided. We used this approach to the transcripts of Clustered Regularly Interspaced Palindromic Repeats (CRISPR) phage defense loci in Escherichia coli. CRISPR loci are transcribed into a single long pre-crRNA, which is then processed at multiple sites to generate ∼60 nt fragments (crRNA) each able to mount defense against a specific phage. The Northern blot technique allowed us to estimate the abundance of individual crRNAs and determine stabilities of both pre-crRNA and crRNA. The procedures described in this chapter can be used with very minor modifications to monitor the abundance and stabilities of transcripts of various lengths from many bacterial sources.


Assuntos
Northern Blotting/métodos , Escherichia coli/genética , Sequências Repetidas Invertidas/genética , RNA Bacteriano/análise , RNA Bacteriano/genética , RNA Mensageiro/análise , Eletroforese em Gel de Poliacrilamida , Formaldeído/química , Marcação por Isótopo , Membranas Artificiais , Hibridização de Ácido Nucleico , Precursores de RNA/genética , Precursores de RNA/isolamento & purificação , RNA Mensageiro/genética , RNA não Traduzido/genética , RNA não Traduzido/isolamento & purificação
7.
J Mol Biol ; 413(5): 1016-27, 2011 Nov 11.
Artigo em Inglês | MEDLINE | ID: mdl-21963987

RESUMO

Escherichia coli T7 bacteriophage gp2 protein is a potent inhibitor of host RNA polymerase (RNAP). gp2 inhibits formation of open promoter complex by binding to the ß' jaw, an RNAP domain that interacts with downstream promoter DNA. Here, we used an engineered promoter with an optimized sequence to obtain and characterize a specific promoter complex containing RNAP and gp2. In this complex, localized melting of promoter DNA is initiated but does not propagate to include the point of the transcription start. As a result, the complex is transcriptionally inactive. Using a highly sensitive RNAP beacon assay, we performed quantitative real-time measurements of specific binding of the RNAP-gp2 complex to promoter DNA and various promoter fragments. In this way, the effect of gp2 on RNAP interaction with promoters was dissected. As expected, gp2 greatly decreased RNAP affinity to downstream promoter duplex. However, gp2 also inhibited RNAP binding to promoter fragments that lacked downstream promoter DNA that interacts with the ß' jaw. The inhibition was caused by gp2-mediated decrease of the RNAP binding affinity to template and non-template strand segments of the transcription bubble downstream of the -10 promoter element. The inhibition of RNAP interactions with single-stranded segments of the transcription bubble by gp2 is a novel effect, which may occur via allosteric mechanism that is set in motion by the gp2 binding to the ß' jaw.


Assuntos
Bacteriófago T7/genética , DNA Bacteriano/genética , RNA Polimerases Dirigidas por DNA/metabolismo , Regiões Promotoras Genéticas/genética , Proteínas Repressoras/genética , Transcrição Gênica , Bacteriófago T7/metabolismo , Sequência de Bases , Pegada de DNA , Sondas de DNA , RNA Polimerases Dirigidas por DNA/genética , Desoxirribonuclease I/metabolismo , Modelos Moleculares , Dados de Sequência Molecular , Ligação Proteica , Proteínas Repressoras/metabolismo , Homologia de Sequência do Ácido Nucleico , Sítio de Iniciação de Transcrição
8.
J Biol Chem ; 280(43): 36176-84, 2005 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-16123036

RESUMO

DNA opening for transcription-competent open promoter complex (OC) formation by the bacterial RNA polymerase (RNAP) relies upon a complex network of interactions between the structurally conserved and flexible modules of the catalytic beta and beta'-subunits, RNAP-associated sigma-subunit, and the DNA. Here, we show that one such module, the beta'-jaw, functions to stabilize the OC. In OCs formed by the major sigma70-RNAP, the stabilizing role of the beta'-jaw is not restricted to any particular melted DNA segment. In contrast, in OCs formed by the major variant sigma54-RNAP, the beta'-jaw and a conserved sigma54 regulatory domain co-operate to stabilize the melted DNA segment immediately upstream of the transcription start site. Clearly, regulated communication between the mobile modules of the RNAP and the functional domain(s) of the sigma subunit is required for stable DNA opening.


Assuntos
RNA Polimerases Dirigidas por DNA/química , DNA/química , Regulação Bacteriana da Expressão Gênica , Regiões Promotoras Genéticas , Thermus/enzimologia , Bacteriófago T7/metabolismo , Sítios de Ligação , Reagentes de Ligações Cruzadas/farmacologia , DNA Bacteriano/genética , Desoxirribonuclease I/metabolismo , Escherichia coli/enzimologia , Heparina/química , Modelos Moleculares , Mutação , Plasmídeos/metabolismo , Permanganato de Potássio/farmacologia , Ligação Proteica , Conformação Proteica , Estrutura Terciária de Proteína , Fatores de Tempo , Transcrição Gênica
9.
EMBO J ; 23(21): 4264-74, 2004 Oct 27.
Artigo em Inglês | MEDLINE | ID: mdl-15470503

RESUMO

We used bacteriophage T7-encoded transcription inhibitor gene protein 2 (gp2) as a probe to study the contribution of the Escherichia coli RNA polymerase (RNAP) beta' subunit jaw domain--the site of gp2 binding--to activator and ATP hydrolysis-dependent open complex formation by the sigma(54)-RNAP. We show that, unlike sigma(70)-dependent transcription, activated transcription by sigma(54)-RNAP is resistant to gp2. In contrast, activator and ATP hydrolysis-independent transcription by sigma(54)-RNAP is highly sensitive to gp2. We provide evidence that an activator- and ATP hydrolysis-dependent conformational change involving the beta' jaw domain and promoter DNA is the basis for gp2-resistant transcription by sigma(54)-RNAP. Our results establish that accessory factors bound to the upstream face of the RNAP, communicate with the beta' jaw domain, and that such communication is subjected to regulation.


Assuntos
RNA Polimerases Dirigidas por DNA/química , RNA Polimerases Dirigidas por DNA/metabolismo , Subunidades Proteicas/química , Subunidades Proteicas/metabolismo , Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , DNA Bacteriano/química , DNA Bacteriano/genética , DNA Bacteriano/metabolismo , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , RNA Polimerases Dirigidas por DNA/genética , Proteínas de Escherichia coli/química , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Regulação Bacteriana da Expressão Gênica , Substâncias Macromoleculares , Modelos Moleculares , Desnaturação de Ácido Nucleico , Regiões Promotoras Genéticas , Ligação Proteica , Conformação Proteica , Subunidades Proteicas/genética , RNA Polimerase Sigma 54 , Proteínas Repressoras/metabolismo , Fator sigma/genética , Fator sigma/metabolismo , Transcrição Gênica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA